Pressure BioSciences Presents Symposium On Applications of PCT Technology
On May 21, 2010 Pressure BioSciences, Inc. (NasdaqCM: PBIO) sponsored a symposium at Harvard Medical School on the “Applications of Ultra-High Pressure in Technology.”
On May 21, 2010 Pressure BioSciences, Inc. (NasdaqCM: PBIO) sponsored a symposium at Harvard Medical School on the “Applications of Ultra-High Pressure in Technology.”
A number of companies are developing minimally invasive devices that produce the weight-reducing effects of a gastric bypass minus the actual surgery.
Each patient who steps into a hospital brings along a complicated tangle of data: current health complaints, medical history, allergies, medication lists and more.
Adolescent idiopathic scoliosis tends to run in families, but determining which patients will develop severe spinal curvature is an inexact science.
A brain cancer vaccine from Immunocellular Therapeutics has yielded positive results in a small Phase I clinical trial.
A compound found in sunless tanning spray may help heal post-surgical wounds.
The New York Times reports that about 75 percent of patients taking telaprevir in combination with existing hepatitis C drugs were essentially cured of the virus, compared to 44 percent on standard therapy alone.
OneMedPlace has announced the first 38 companies to be presenting at the OneMedForum New York 2010 investor conference on June 29-30.
Millions of Americans suffer from sleep apnea, a disorder in which the patient repeatedly stops breathing during sleep.
On May 21, Abbott Laboratories announced that it would purchase Piramal Healthcare, a branded generics company based in India, for $3.72 billion.
Copyright © 2025 | WordPress Theme by MH Themes